TOPICAL ISSUES OF OSTEOARTHRITIS TREATMENT IN CLINICAL PRACTICE

TOPICAL ISSUES OF OSTEOARTHRITIS TREATMENT IN CLINICAL PRACTICE

The article is devoted to the treatment of osteoarthritis - one of the most common diseases of the musculoskeletal system, causing pain, reduced quality of life, restricting social activity and disability. Data are provided about the effectiveness of the original drug crystalline glucosamine sulphat...

Full description

Bibliographic Details
Main Authors:	L. K. Poshekhonova, D. V. Poshekhonov, P. A. Krasyukov
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2017-12-01
Series:	Медицинский совет
Subjects:	osteoarthritis pain symptom-modifying drugs slow motion crystalline glucosamine sulfate
Online Access:	https://www.med-sovet.pro/jour/article/view/1668

Similar Items

THE EUROPEAN SOCIETY FOR CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS AND OSTEOARTHRITIS (ESCEO) ALGORITHM FOR THE MANAGEMENT OF KNEE OSTEOARTHRITIS IS APPLICABLE TO RUSSIAN CLINICAL PRACTICE: A CONSENSUS STATEMENT OF LEADING RUSSIAN AND ESCEO OSTEOARTHRITIS EXPERTS
by: L. N. Denisov, et al.
Published: (2017-01-01)

Treatment in patients with osteoarthritis at different sites: Place of slow-acting drugs
by: N. V. Chichasova, et al.
Published: (2015-06-01)

Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
by: E. V. Zonova
Published: (2021-04-01)

Effects of modern chondroprotectors in osteoarthritis
by: V. V. Kosarev, et al.
Published: (2014-12-01)

MODERN INTERNATIONAL AND NATIONAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH OSTEOARTHRITIS ISSUES OF STRATEGY AND TACTICS
by: N. V. Chichasova
Published: (2017-12-01)

Modern aspects of the pathogenetic therapy of osteoarthritis
by: V. V. Badokin
Published: (2013-12-01)

SLOW-ACTING ANTI-ARTHROSIS MEDICATIONS FOR THE TREATMENT OF OSTEOARTHRITIS
by: M. S. SVETLOVA
Published: (2016-12-01)

Osteoarthritis background therapy: current view on the glucosamine and chondroitin therapy
by: L. I. Alekseeva, et al.
Published: (2021-04-01)

Acute issues in the pharmacotherapy of hand osteoarthritis
by: O. A. Gromova, et al.
Published: (2021-02-01)

CLINICAL AND SONOGRAPHIC ASSESSMENT OF SYNOVITIS ACTIVITY IN PATIENTS WITH KNEE OSTEOARTHRITIS DURING THERAPY
by: A. V. Petrov, et al.
Published: (2016-02-01)

Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial
by: Andri M.T. Lubis, et al.
Published: (2017-04-01)

Modern clinical-pharmaceutical approaches to the treatment of osteoarthrosis: role of combination drugs (chondroitin sulfate + glucosamine hydrochloride)
by: V. V. Kosarev, et al.
Published: (2013-12-01)

Effectiveness of Glucosamine and Chondroitin Sulfate Combination in Patients with Primary Osteoarthritis
by: Laszlo IRSAY, et al.
Published: (2010-12-01)

The management of patients with osteoarthritis by a primary care physician: focus on efficacy and safety
by: M. S. Svetlova
Published: (2018-05-01)

Osteoarthritis: Key elements in its pathogenesis and current agents for pathogenetic therapy
by: Yu. A. Olyunin, et al.
Published: (2017-09-01)

Evaluation of the efficacy and safety of a combination of chondroitin sulfate and glucosamine sulfate for knee and hip osteoarthritis in real clinical practice
by: A. E. Karateev, et al.
Published: (2020-11-01)

Treatment of osteoarthritis: A focus on nimesulide
by: G. R. Imametdinova, et al.
Published: (2017-04-01)

Use of Artra and Artra MSM Forte in osteoarthritis of the large joints and lowback pain
by: E. P. Sharapova, et al.
Published: (2019-06-01)

Repairing effects of glucosamine sulfate in combination with etoricoxib on articular cartilages of patients with knee osteoarthritis
by: Yong Sun, et al.
Published: (2020-04-01)

Multicenter, randomized, double-blind clinical trial to evaluate efficacy and safety of combined glucosamine sulfate and chondroitin sulfate capsules for treating knee osteoarthritis
by: Andrea Barranjard Vannucci Lomonte, et al.
Published: (2018-12-01)

Gross Morphology Analysis of Osteoarthritis in Rabbits
by: Svätoslav Hluchý
Published: (2017-05-01)

The role of chondroprotectors in the pharmacological treatment of osteoarthritis
by: L. K. Peshekhonova, et al.
Published: (2019-04-01)

Showiness or efficiency: what to choose?
by: D.G. Rekalov, et al.
Published: (2013-08-01)

Efficacy of glucosamine sulfate in lowering serum level of interleukin-1β in symptomatic primary knee osteoarthritis: Clinical and laboratory study
by: Enas M. Shahine, et al.
Published: (2014-06-01)

Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial
by: Andrea Barranjard Vannucci Lomonte, et al.
Published: (2021-01-01)

Many years of experience in using a combination of glucosamine and chondroitin in clinical practice
by: I. S. Dydykina, et al.
Published: (2020-07-01)

A new look at back pain treatment in light of the latest ESCEO guidelines
by: O. A. Shavlovskaya, et al.
Published: (2020-12-01)

Analysis of the Health and Budgetary Impact of Chondroitin Sulfate Prescription in the Treatment of Knee Osteoarthritis Compared to NSAIDs and COXIBs
by: Rubio-Terrés C, et al.
Published: (2020-09-01)

ON ROLE OF CHONDROPROTECTIVE AGENTS IN OSTEOARTHRITIS: ON THE WAY TO THE EVIDENCE-BASED MEDICINE
by: S. V. Jargin
Published: (2016-11-01)

Symptom-modifying slow-acting drugs in the treatment of osteoarthritis: from molecule to clinical effect (a pharmacologist's view)
by: A. S. Dukhanin
Published: (2018-06-01)

The efficacy and tolerability of the slow-acting combined agent glucosamine and chondroitin sulfate in gonarthrosis patients tacking no nonsteroidal anti-inflammatory drugs
by: A. P. Rebrov, et al.
Published: (2016-01-01)

Cardiovascular safety and efficacy of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with gonarthrosis
by: A. P. Rebrov, et al.
Published: (2016-06-01)

The clinical status and treatment options for osteoarthritis in patients with frailty
by: A V Naumov, et al.
Published: (2019-12-01)

CURRENT PHARMACOTHERAPY FOR KNEE OSTEOARTHRITIS: SPECIFIC FEATURES OF SYMPTOMATIC AND DISEASE MODIFYING EFFECTS. COMMUNICATION 1. SPECIFIC FEATURES OF THE SYMPTOMATIC EFFECTS OF CURRENT DRUGS TO TREAT KNEE OSTHEOARTHRITIS
by: E. S. Tsvetkova, et al.
Published: (2015-03-01)

Combined chondroprotectors in the treatment of osteoartritis
by: L.V. Derymedvid, et al.
Published: (2018-02-01)

The effect of glucosamine, chondroitin and harpagophytum procumbens on femoral hyaline cartilage thickness in patients with knee osteoarthritis– An MRI versus ultrasonography study
by: Florentin A. Vreju, et al.
Published: (2019-05-01)

Use of a glycosamine sulfate for patients with osteoarthritis and a comorbidity with high risk of the side effects from NSAIDS
by: A V Naumov, et al.
Published: (2018-05-01)

A Malaysian Delphi consensus on managing knee osteoarthritis
by: Abu Amin, SR, et al.
Published: (2021)

Histological Changes of Cartilage Degeneration in Osteoarthritic Rabbits
by: Svätoslav Hluchý
Published: (2018-05-01)

A Combination of Celecoxib and Glucosamine Sulfate Has Anti-Inflammatory and Chondroprotective Effects: Results from an In Vitro Study on Human Osteoarthritic Chondrocytes
by: Sara Cheleschi, et al.
Published: (2021-08-01)

Cannot write session to /tmp/vufind_sessions/sess_pcotgfmmhsaaoc4n0456etvi47